XKRX
097955
Market cap2.01bUSD
Oct 08, Last price
110,300.00KRW
1D
0.09%
1Q
-10.03%
Jan 2017
-36.24%
IPO
23.52%
Name
CJ CheilJedang Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
CJ Cheiljedang Corporation is an enterprise involved in both the food and biotechnology sectors. The company's diverse food product range encompasses prepared meats, frozen meals, fresh produce, a variety of seasonings, sweeteners, flours, cooking oils, starches, along with specialty items such as seaweed, desserts, snacks, and health-functional foods. In its bio division, it manufactures amino acids and animal feed. Established in 1953, CJ Cheiljedang Corporation is based in Seoul, South Korea.
Related entities
Subsidiaries (7)
CJ CHINA LIMITED
CJ Europe GmbH
CJ Feed&Care Corporation
CJ SCHWAN'S DE CORP.
PT Cheil Jedang Indonesia
PT CHEIL JEDANG SUPERFEED
Key people
Chairman · since 2018
Sin Ho Kang
Co-Chief Executive Officer, Vice Chairman · since 2024
Jae Yeol Cho
Chief Operating Officer - Digital Farm CIC · since 2024
Jae Seok Oh
Chief Financial Officer - Food · since 2024
Hyeong Jun Lee
Director · since 2025
Chairman, Co-Chief Executive Officer · since 2024
Hwang Geun Jung
Non-Executive Independent Director · since 2025
Jong Chang Kim
Non-Executive Independent Director · since 2019
Non-Executive Independent Director · since 2019
Yong Deok Kim
Non-Executive Independent Director · since 2024
Hye Yeong Kim
Non-Executive Independent Director · since 2025
Jeong Hwan Yoon
Non-Executive Independent Director · since 2020
Headquarters & legal address
서울특별시 중구 동호로 330 (쌍림동)
CJ 제일제당센터
Seoul, 11 10040
KR
CJ 제일제당센터
Seoul, 11 10040
KR
Address
330, Donghoro, Jung-gu, Seoul
CJ CHEILJEDANG CENTER
Seoul, 11 10040
KR
CJ CHEILJEDANG CENTER
Seoul, 11 10040
KR
Other language
CJ CheilJedang Corp.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||